{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:14:19Z","timestamp":1790802859040,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.ejphar.2023.175891","type":"journal-article","created":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T05:59:50Z","timestamp":1688795990000},"page":"175891","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Hyodeoxycholic acid attenuates cholesterol gallstone formation via modulation of bile acid metabolism and gut microbiota"],"prefix":"10.1016","volume":"955","author":[{"given":"Shuang","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengnan","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4201-633X","authenticated-orcid":false,"given":"Xinjian","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixia","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ejphar.2023.175891_bib1","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0022-2275(20)38774-5","article-title":"Cholesterol gallstones in alloxan-diabetic mice","volume":"27","author":"Akiyoshi","year":"1986","journal-title":"J. Lipid Res."},{"issue":"8","key":"10.1016\/j.ejphar.2023.175891_bib46","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0022-2275(20)40677-7","article-title":"Critical tables for calculating the cholesterol saturation of native bile","volume":"19","author":"Carey","year":"1978","journal-title":"J. Lipid. Res."},{"key":"10.1016\/j.ejphar.2023.175891_bib2","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1172\/JCI111459","article-title":"Effects of acute changes of bile acid pool composition on biliary lipid secretion","volume":"74","author":"Carulli","year":"1984","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.ejphar.2023.175891_bib3","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0016-5085(90)90831-K","article-title":"Bile acids substituted in the 6 position prevent cholesterol gallstone formation in the hamster","volume":"98","author":"Cohen","year":"1990","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.ejphar.2023.175891_bib4","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/BF02534055","article-title":"A hydrophilic bile acid effects partial dissolution of cholesterol gallstones in the prairie dog","volume":"21","author":"Cohen","year":"1986","journal-title":"Lipids"},{"issue":"2","key":"10.1016\/j.ejphar.2023.175891_bib5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/MOG.0000000000000423","article-title":"An update on the pathogenesis of cholesterol gallstone disease","volume":"34","author":"Di Ciaula","year":"2018","journal-title":"Curr. Opin. Gastroenterol."},{"issue":"2","key":"10.1016\/j.ejphar.2023.175891_bib6","article-title":"Low-phospholipid-associated cholelithiasis syndrome: prevalence, clinical features, and comorbidities","volume":"3","author":"Dong","year":"2021","journal-title":"JHEP Rep"},{"issue":"1","key":"10.1016\/j.ejphar.2023.175891_bib7","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12944-020-01334-3","article-title":"The effect of ursodeoxycholic acid on the relative expression of the lipid metabolism genes in mouse cholesterol gallstone models","volume":"19","author":"Fan","year":"2020","journal-title":"Lipids Health Dis."},{"issue":"6","key":"10.1016\/j.ejphar.2023.175891_bib8","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1111\/liv.14423","article-title":"Absence of Bsep\/Abcb11 attenuates MCD diet-induced hepatic steatosis but aggravates inflammation in mice","volume":"40","author":"Fuchs","year":"2020","journal-title":"Liver Int."},{"issue":"1","key":"10.1016\/j.ejphar.2023.175891_bib9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1507\/endocrj.KR07E-002","article-title":"Actions and mode of actions of FGF19 subfamily members","volume":"55","author":"Fukumoto","year":"2008","journal-title":"Endocr. J."},{"key":"10.1016\/j.ejphar.2023.175891_bib10","doi-asserted-by":"crossref","first-page":"G450","DOI":"10.1152\/ajpgi.00391.2014","article-title":"The mechanism of increased biliary lipid secretion in mice with genetic inactivation of bile salt export pump","volume":"308","author":"Gooijert","year":"2015","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.ejphar.2023.175891_bib11","doi-asserted-by":"crossref","first-page":"g2669","DOI":"10.1136\/bmj.g2669","article-title":"Gallstones","volume":"348","author":"Gurusamy","year":"2014","journal-title":"BMJ"},{"issue":"20","key":"10.1016\/j.ejphar.2023.175891_bib12","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.jacc.2014.02.553","article-title":"Opposing effects of ABCG5\/8 function on myocardial infarction and gallstone disease","volume":"63","author":"Hancock-Cerutti","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"7","key":"10.1016\/j.ejphar.2023.175891_bib13","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/sj.emboj.7601049","article-title":"Endocrine functions of bile acids","volume":"25","author":"Houten","year":"2006","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.ejphar.2023.175891_bib14","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41467-021-27758-8","article-title":"Gut microbiota promotes cholesterol gallstone formation by modulating bile acid composition and biliary cholesterol secretion","volume":"13","author":"Hu","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejphar.2023.175891_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.664177","article-title":"The nonsteroidal anti-inflammatory drug ketorolac alters the small intestinal microbiota and bile acids without inducing intestinal damage or delaying peristalsis in the rat","volume":"12","author":"Hutka","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2023.175891_bib16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrgastro.2017.119","article-title":"Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis","volume":"15","author":"Jia","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.ejphar.2023.175891_bib17","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/hep.25740","article-title":"Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice","volume":"56","author":"Kong","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2023.175891_bib18","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1194\/jlr.R088989","article-title":"Microbial impact on cholesterol and bile acid metabolism: current status and future prospects","volume":"60","author":"Kriaa","year":"2019","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejphar.2023.175891_bib19","article-title":"Gallstones","volume":"2","author":"Lammert","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"5418","key":"10.1016\/j.ejphar.2023.175891_bib20","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1126\/science.284.5418.1362","article-title":"Identification of a nuclear receptor for bile acids","volume":"284","author":"Makishima","year":"1999","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ejphar.2023.175891_bib21","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0002-9610(85)80021-0","article-title":"Hyodeoxycholic acid: a new approach to gallstone prevention","volume":"149","author":"McSherry","year":"1985","journal-title":"Am. J. Surg."},{"issue":"7","key":"10.1016\/j.ejphar.2023.175891_bib22","doi-asserted-by":"crossref","DOI":"10.1111\/eci.12935","article-title":"Genetics of gallstone disease","volume":"48","author":"Rebholz","year":"2018","journal-title":"Eur. J. Clin. Invest."},{"issue":"21","key":"10.1016\/j.ejphar.2023.175891_bib23","doi-asserted-by":"crossref","first-page":"18793","DOI":"10.1074\/jbc.M109927200","article-title":"Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta","volume":"277","author":"Repa","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2023.175891_bib24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/19490976.2015.1127483","article-title":"Consequences of bile salt biotransformations by intestinal bacteria","volume":"7","author":"Ridlon","year":"2016","journal-title":"Gut Microb."},{"issue":"2","key":"10.1016\/j.ejphar.2023.175891_bib25","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1053\/j.gastro.2010.10.060","article-title":"Gallstone disease is associated with increased mortality in the United States","volume":"140","author":"Ruhl","year":"2011","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.ejphar.2023.175891_bib26","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0092-8674(00)80763-1","article-title":"Nuclear orphan receptors control cholesterol catabolism","volume":"97","author":"Russell","year":"1999","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.ejphar.2023.175891_bib27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","article-title":"Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist","volume":"17","author":"Sayin","year":"2013","journal-title":"Cell Metabol."},{"key":"10.1016\/j.ejphar.2023.175891_bib28","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/eci.1971.1.4.242","article-title":"Relationship between the biliary excretion of bile acids and the excretion of water, lecithin, and cholesterol in man","volume":"1","author":"Schersten","year":"1971","journal-title":"Eur. J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.ejphar.2023.175891_bib29","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/S0022-2275(20)31575-3","article-title":"Hyodeoxycholic acid efficiently suppresses atherosclerosis formation and plasma cholesterol levels in mice","volume":"42","author":"Sehayek","year":"2001","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.ejphar.2023.175891_bib30","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12944-020-01402-8","article-title":"An inverse association of weight and the occurrence of asymptomatic gallbladder stone disease in hypercholesterolemia patients: a case-control study","volume":"19","author":"Sheng","year":"2020","journal-title":"Lipids Health Dis."},{"issue":"9","key":"10.1016\/j.ejphar.2023.175891_bib31","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1096\/fj.12-223008","article-title":"Hyodeoxycholic acid improves HDL function and inhibits atherosclerotic lesion formation in LDLR-knockout mice","volume":"27","author":"Shih","year":"2013","journal-title":"Faseb. J."},{"issue":"6","key":"10.1016\/j.ejphar.2023.175891_bib32","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0022-2275(20)37766-X","article-title":"Prevention of cholesterol-induced gallstones by hyodeoxycholic acid in the prairie dog","volume":"25","author":"Singhal","year":"1984","journal-title":"J. Lipid Res."},{"issue":"5","key":"10.1016\/j.ejphar.2023.175891_bib33","doi-asserted-by":"crossref","first-page":"7103","DOI":"10.1096\/fj.201903244R","article-title":"Hyodeoxycholic acid (HDCA) suppresses intestinal epithelial cell proliferation through FXR-PI3K\/AKT pathway, accompanied by alteration of bile acids metabolism profiles induced by gut bacteria","volume":"34","author":"Song","year":"2020","journal-title":"Faseb. J."},{"issue":"3","key":"10.1016\/j.ejphar.2023.175891_bib34","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jhep.2020.04.036","article-title":"Variants in ABCB4 (MDR3) across the spectrum of cholestatic liver diseases in adults","volume":"73","author":"Stattermayer","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2023.175891_bib35","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000450982","article-title":"Crosstalk between bile acids and gut microbiota and its impact on farnesoid X receptor signalling","volume":"35","author":"Wahlstrom","year":"2017","journal-title":"DIGEST DIS"},{"issue":"1","key":"10.1016\/j.ejphar.2023.175891_bib36","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","article-title":"Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism","volume":"24","author":"Wahlstrom","year":"2016","journal-title":"Cell Metabol."},{"issue":"Suppl. l","key":"10.1016\/j.ejphar.2023.175891_bib37","doi-asserted-by":"crossref","first-page":"S406","DOI":"10.1194\/jlr.R800075-JLR200","article-title":"Biliary lipids and cholesterol gallstone disease","volume":"50","author":"Wang","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejphar.2023.175891_bib38","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1194\/jlr.M200297-JLR200","article-title":"Effect of beta-muricholic acid on the prevention and dissolution of cholesterol gallstones in C57L\/J mice","volume":"43","author":"Wang","year":"2002","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejphar.2023.175891_bib39","doi-asserted-by":"crossref","DOI":"10.1039\/D1FO03464B","article-title":"Oryzanol alleviates high fat and cholesterol diet-induced hypercholesterolemia associated with the modulation of the gut microbiota in hamsters","author":"Yan","year":"2022","journal-title":"Food Funct."},{"key":"10.1016\/j.ejphar.2023.175891_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174341","article-title":"Sodium butyrate alleviates cholesterol gallstones by regulating bile acid metabolism","volume":"908","author":"Ye","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.ejphar.2023.175891_bib41","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1172\/JCI0216001","article-title":"Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol","volume":"110","author":"Yu","year":"2002","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.ejphar.2023.175891_bib42","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.surg.2011.07.008","article-title":"Bile salt supplementation acts via the farnesoid X receptor to alleviate lipopolysaccharide-induced intestinal injury","volume":"150","author":"Zahiri","year":"2011","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.ejphar.2023.175891_bib43","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12944-022-01635-9","article-title":"Blood lipid metabolism and the risk of gallstone disease: a multi-center study and meta-analysis","volume":"21","author":"Zhang","year":"2022","journal-title":"Lipids Health Dis."},{"issue":"4","key":"10.1016\/j.ejphar.2023.175891_bib44","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.cmet.2020.11.017","article-title":"Hyocholic acid species improve glucose homeostasis through a distinct TGR5 and FXR signaling mechanism","volume":"33","author":"Zheng","year":"2021","journal-title":"Cell Metabol."},{"key":"10.1016\/j.ejphar.2023.175891_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.701003","article-title":"Astragalus polysaccharides ameliorate diet-induced gallstone formation by modulating synthesis of bile acids and the gut microbiota","volume":"12","author":"Zhuang","year":"2021","journal-title":"Front. Pharmacol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923004028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299923004028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T14:19:13Z","timestamp":1736345953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299923004028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":46,"alternative-id":["S0014299923004028"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.175891","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyodeoxycholic acid attenuates cholesterol gallstone formation via modulation of bile acid metabolism and gut microbiota","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2023.175891","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"175891"}}